Home > DARE Reviews > Meta-analysis of medical intervention...
  • We are sorry, but NCBI web applications do not support your browser and may not function properly. More information

PubMed Health. A service of the National Library of Medicine, National Institutes of Health.

Database of Abstracts of Reviews of Effects (DARE): Quality-assessed Reviews [Internet]. York (UK): Centre for Reviews and Dissemination (UK); 1995-.

Database of Abstracts of Reviews of Effects (DARE): Quality-assessed Reviews.

Meta-analysis of medical intervention for normal tension glaucoma

Review published: 2009.

Bibliographic details: Cheng JW, Cai JP, Wei RL.  Meta-analysis of medical intervention for normal tension glaucoma. Ophthalmology 2009; 116(7): 1243-1249. [PubMed: 19450880]

Quality assessment

The authors concluded that latanoprost, bimatoprost and timolol were the most effective intraocular pressure lowering agents in patients with normal tension glaucoma. However, the method of combining studies in this review appeared to be inappropriate and therefore the conclusions must be treated with some caution. Full critical summary


OBJECTIVE: To evaluate the intraocular pressure (IOP) reduction achieved by the most frequently prescribed antiglaucoma drugs in patients with normal tension glaucoma (NTG).

DESIGN: Systematic review and meta-analysis.

PARTICIPANTS: Fifteen randomized clinical trials reported 25 arms for peak IOP reduction, 16 arms for trough IOP reduction, and 13 arms for diurnal curve IOP reduction.

METHODS: Pertinent publications were identified through systematic searches of PubMed, EMBASE, and the Cochrane Controlled Trials Register. The patients had to be diagnosed as having NTG. Methodological quality was assessed by the Delphi list on a scale from 0 to 18. The pooled 1-month IOP-lowering effects were calculated using the 2-step DerSimonian and Laird estimate method of the random effects model.

MAIN OUTCOME MEASURES: Absolute and relative reductions in IOP from baseline for peak and trough moments.

RESULTS: Quality scores of included studies were generally high, with a mean quality score of 12.7 (range, 9-16). Relative IOP reductions were peak, 15% (12%-18%), and trough, 18% (8%-27%) for timolol; peak, 14% (8%-19%), and trough, 12% (-7% to 31%) for dorzolamide; peak, 24% (17%-31%), and trough, 11% (7%-14%) for brimonidine; peak, 20% (17%-24%), and trough, 20% (18%-23%) for latanoprost; peak, 21% (16%-25%), and trough, 18% (14%-22%) for bimatoprost. The differences in absolute IOP reductions between prostaglandin analogues and timolol varied from 0.9 to 1.0 mmHg at peak and -0.1 to 0.2 mmHg at trough.

CONCLUSIONS: Latanoprost, bimatoprost, and timolol are the most effective IOP-lowering agents in patients with NTG.

CRD has determined that this article meets the DARE scientific quality criteria for a systematic review.

Copyright © 2013 University of York.

PubMed Health Blog...

read all...

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...